Video Experimental Relacionado
Updated: Feb 19, 2026

Reproducible Manufacturing of SPOT as a High-throughput Scaffold-based Culture Platform
Published on: July 29, 2025
Desde el control de estado sólido hasta la precisión predictiva: Construcción de un ecosistema desplegable para
Anna C Renner1, Robert B Kargbo2
1North Dakota State University, Fargo, North Dakota 58108-6050, United States.
Abstract:
Two recent patent applications illustrate how psychedelic drug development is expanding beyond molecules and experiences toward deployable therapeutic systems. One focuses on solid-state optimization of a lysergamide analogue to ensure manufacturability and stability, while the other applies machine-learning-driven neurophysiological biomarkers to predict patient response. Together, they address complementary translational bottlenecks in psychedelic medicine.
Videos de Conceptos Relacionados
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
CNS Stimulants: Psychedelic Agents
Modified-Release Drug Delivery Systems: Stimuli-Activated

